来自专业的译者、企业、网页和免费的翻译库。
koncentrationen af ethinylestradiol og norethindron øges, når et kombineret oralt kontraceptivum indeholdende disse stoffer administreres sammen med atazanavir.
concentrations of ethinyl estradiol and norethindrone are increased when a combined oral contraceptive containing those agents is co-administered with atazanavir.
i kliniske studier af raske forsøgspersoner påvirkede ligevægtsdosering med zonisamid ikke serumkoncentrationen af ethinylestradiol eller norethisteron i et kombineret oralt kontraceptivum.
in clinical studies in healthy subjects, steady-state dosing with zonisamide did not affect serum concentrations of ethinylestradiol or norethisterone in a combined oral contraceptive.
perorale kontraceptiva i kliniske undersøgelser af raske forsøgspersoner påvirkede ligevægtsdosering med zonegran ikke serumkoncentrationen af ethinylestradiol eller norethisteron i et kombineret peroralt kontraceptivum.
oral contraceptives in clinical studies in healthy subjects, steady-state dosing with zonegran did not affect serum concentrations of ethinylestradiol or norethisterone in a combined oral contraceptive.
hvis patienten aktuelt bruger et oralt kontraceptivum eller en hormonel kontraceptionsmetode, der er forbundet med risiko for trombose, skal hun skifte til anden sikker kontraception.
if a patient is currently using oral contraceptives or a hormonal method of contraception that is associated with a risk of thrombosis, the patient should switch to an alternative method of effective contraception.
ivacaftor er blevet undersøgt sammen med oral kontraception indeholdende østrogen/progesteron, og der blev ikke fundet nogen signifikant indvirkning på eksponeringen for det orale kontraceptivum.
ivacaftor has been studied with an oestrogen/progesterone oral contraceptive and was found to have no significant effect on the exposures of the oral contraceptive.
i kliniske studier af raske forsøgspersoner påvirkede steady-state-dosering med zonegran ikke serumkoncentrationen af ethinylestradiol eller norethisteron i et kombineret oralt kontraceptivum.
in clinical studies in healthy subjects, steady-state dosing with zonegran did not affect serum concentrations of ethinylestradiol or norethisterone in a combined oral contraceptive.
det anbefales at øge lamotrigin- dosis med 50 til 100 mg/ dag hver uge i henhold til den enkelte patients kliniske respons fra det tidspunkt, hvor det hormonale kontraceptivum initieres.
it is recommended that from the time that the hormonal contraceptive is started, the lamotrigine dose is increased by 50 to 100 mg/ day every week, according to the individual clinical response.
administration af et oralt kontraceptivum som kombinationsbehandling (30 mikrogram ethinylestradiol plus 150 mikrogram levonorgestrel) 1 time inden exenatid opløsning til injektion ændrede ikke auc, cmax eller cmin for hverken ethinylestradiol eller levonorgestrel.
administration of a combination oral contraceptive (30 mcg ethinyl estradiol plus 150 mcg levonorgestrel) one hour before immediate-release exenatide did not alter the auc, cmax or cmin of either ethinyl estradiol or levonorgestrel.
der er udført specifikke interaktionsundersøgelser for indinavir i forbindelse med følgende lægemidler:zidovudin, zidovudin/lamivudin, stavudin, trimethoprim/sulfamethoxazol, fluconazol, isoniazid, clarithromycin, quinidin, cimetidin, theophyllin, metadon og et oralt kontraceptivum (norethisteron/ethinylestradiol 1/35) .
specific interaction studies were performed with indinavir and the following medicinal products: zidovudine, zidovudine/lamivudine, stavudine, trimethoprim/sulfamethoxazole, fluconazole, isoniazid, clarithromycin, quinidine, cimetidine, theophylline, methadone and an oral contraceptive (norethindrone/ethinyl estradiol 1/35) .